Generic Injectables Market Scope And Analysis

  • Report Code : TIPRE00004765
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 217
Buy Now

Generic Injectables Market Scope and Analysis Report - 2031

Buy Now


Generic Injectables Market Report Scope

Report Attribute Details
Market size in 2021 US$ 74.74 Billion
Market Size by 2028 US$ 150.65 Billion
Global CAGR (2021 - 2028) 10.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Large Molecule Injectables and Small Molecule Injectables
By Container Type
  • Vials
  • Premix
  • Prefilled Syringes
  • Ampoules
By Application
  • Oncology
  • Infectious Diseases
  • Cardiology
  • Diabetes
  • Immunology
By Route of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Astrazeneca
  • Baxter International Inc
  • Biocon
  • Fresenius SE Co KGaA
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals
  • Johnson Johnson Services Inc
  • Lupin Ltd
  • Merck Co Inc